Rapid Inactivation In Vitro of SARS-CoV-2 in Saliva by Black Tea and Green Tea.
COVID-19
catechin
novel coronavirus
saliva
tea
theaflavin
Journal
Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317
Informations de publication
Date de publication:
08 Jun 2021
08 Jun 2021
Historique:
received:
05
05
2021
revised:
01
06
2021
accepted:
04
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Saliva plays major roles in the human-to-human transmission of SARS-CoV-2. If the virus in saliva in SARS-CoV-2-infected individuals can be rapidly and efficiently inactivated by a beverage, the ingestion of the beverage may attenuate the spread of virus infection within a population. Recently, we reported that SARS-CoV-2 was significantly inactivated by treatment with black tea, green tea, roasted green tea and oolong tea, as well as their constituents, (-) epigallocatechin gallate (EGCG), theasinensin A (TSA), and galloylated theaflavins. However, it remains unclear to what extent tea inactivates the virus present in saliva, because saliva contains various proteins, nitrogenous products, electrolytes, and so on, which could influence the antivirus effect of tea. Here, we assessed whether tea inactivated the SARS-CoV-2 which was added in human saliva. A virus was added in healthy human saliva in vitro, and after treatment with black tea or green tea, the infectivity of the virus was evaluated by TCID
Identifiants
pubmed: 34201131
pii: pathogens10060721
doi: 10.3390/pathogens10060721
pmc: PMC8227886
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Antiinflamm Antiallergy Agents Med Chem. 2016;15(2):74-90
pubmed: 27634207
Anaesthesiol Intensive Ther. 2020;52(2):171-172
pubmed: 32200613
Mol Oral Microbiol. 2020 Aug;35(4):141-145
pubmed: 32367576
Molecules. 2018 Sep 13;23(9):
pubmed: 30217074
J Korean Med Sci. 2020 May 25;35(20):e195
pubmed: 32449329
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7001-7003
pubmed: 32165541
Clin Cancer Res. 2005 Jun 15;11(12):4627-33
pubmed: 15958649
Eur J Clin Microbiol Infect Dis. 2020 Nov;39(11):2005-2011
pubmed: 32638221
Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1025-32
pubmed: 12376503
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):629-630
pubmed: 32405602
Int J Oral Sci. 2020 Apr 17;12(1):11
pubmed: 32300101
JAMA. 2020 Aug 4;324(5):441-442
pubmed: 32749495
Food Funct. 2014 Aug;5(8):1891-7
pubmed: 24947273
J Agric Food Chem. 2017 Jul 5;65(26):5365-5374
pubmed: 28595385
Molecules. 2017 Aug 12;22(8):
pubmed: 28805687
Nat Med. 2021 May;27(5):892-903
pubmed: 33767405
Curr Med Chem. 2016;23(42):4773-4783
pubmed: 27881069
Int J Oral Sci. 2020 Mar 3;12(1):9
pubmed: 32127517
Molecules. 2021 Jun 11;26(12):
pubmed: 34208050
Evid Based Dent. 2020 Jun;21(2):68-70
pubmed: 32591666
Clin Transl Med. 2020 Oct;10(6):e212
pubmed: 33135340
Biochem Pharmacol. 2011 Dec 15;82(12):1807-21
pubmed: 21827739
Front Med (Lausanne). 2020 Jun 09;7:310
pubmed: 32582747
Aliment Pharmacol Ther. 2020 May;51(9):843-851
pubmed: 32222988
Pathogens. 2021 Jun 08;10(6):
pubmed: 34201131
J Prosthet Dent. 2001 Feb;85(2):162-9
pubmed: 11208206